Viewing Study NCT01385657


Ignite Creation Date: 2025-12-24 @ 6:41 PM
Ignite Modification Date: 2025-12-30 @ 1:32 PM
Study NCT ID: NCT01385657
Status: COMPLETED
Last Update Posted: 2020-02-26
First Post: 2011-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module